Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.985
+0.025 (1.28%)
Jul 22, 2025, 1:37 PM - Market open

Ernexa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
15151017217-
Upgrade
Market Cap Growth
-28.38%55.53%-41.17%-92.39%--
Upgrade
Enterprise Value
1549456196-
Upgrade
Last Close Price
1.964.4126.9248.301251.00-
Upgrade
PS Ratio
6.2625.95142.82---
Upgrade
PB Ratio
-8.884.351.368.51-
Upgrade
P/TBV Ratio
--51.661.649.25-
Upgrade
EV/Sales Ratio
28.7783.40658.24---
Upgrade
Debt / Equity Ratio
-0.480.4018.740.100.110.38
Upgrade
Asset Turnover
0.020.020.00---
Upgrade
Quick Ratio
0.200.741.221.624.810.52
Upgrade
Current Ratio
0.210.801.461.795.100.55
Upgrade
Return on Equity (ROE)
--2264.31%-302.20%-130.70%-739.07%-83.79%
Upgrade
Return on Assets (ROA)
-32.42%-39.64%-36.19%-63.25%-77.17%-32.34%
Upgrade
Return on Capital (ROIC)
-43.30%-46.41%-45.05%-81.98%-88.41%-43.53%
Upgrade
Earnings Yield
-319.59%-294.88%-223.12%-148.88%-56.47%-
Upgrade
FCF Yield
-99.96%-107.29%-210.34%-128.86%-10.89%-
Upgrade
Buyback Yield / Dilution
-376.06%-156.81%-74.17%-40.92%-146.19%-
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q